Leadership & Pay ·
BioRestorative Therapies, Inc. announced the resignations of CEO Lance Alstodt, CFO Robert Kristal, and Director David…
BRTXBioRestorative Therapies, Inc.
BioRestorative Therapies, Inc. announced the resignations of CEO Lance Alstodt, CFO Robert Kristal, and Director David Rosa, effective July 13, 2026. Katharyn Field was appointed as CEO, President, and interim CFO, Treasurer, and Secretary. The company is investigating the validity of the executives' claims of a Change in Control that would trigger approximately $2.85 million in severance. BioRestorative Therapies, Inc. is a biotechnology company focused on developing cell therapy products.